Learn about the global clinical oncology next generation sequencing market through The Business Research Company, which provides information on clinical oncology next generation sequencing market size, clinical oncology next generation sequencing market drivers and restraints, clinical oncology next generation sequencing market players, the COVID-19 impact on the clinical oncology next generation sequencing market, and more.

Last chance at deals on TBRC’s market research reports! Get the best offer today.

The global clinical oncology next generation sequencing market is expected to grow from $0.44 billion in 2020 to $0.56 billion in 2021 at a compound annual growth rate (CAGR) of 27.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global clinical oncology next generation sequencing market is expected to reach $1.05 billion in 2025 at a CAGR of 17%.

The rise in the number of cancer cases across the globe is expected to drive innovation in clinical oncology next generation sequencing, thus driving the market during the forecast period.

Request A Sample For The Global Clinical Oncology Next Generation Sequencing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3344&type=smph

The clinical oncology next generation sequencing market consists of sales of devices and equipment used in clinical oncology next generation sequencing and related services by entities (organizations, sole traders and partnerships) that manufacture clinical oncology next generation sequencing equipment. Next generation sequencing is a process used to determine the sequence of nucleotides in a section of DNA and is used for oncology research. Only goods and services traded between entities or sold to end consumers are included.

Global clinical oncology next generation sequencing market segments include:

By Technology: Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing

By Application: Screening, Companion Diagnostics, Other Diagnostics

By End User: Hospital Laboratories, Clinical Research Organizations, Diagnostic Laboratories

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Companies in the clinical oncology next generation sequencing are increasingly investing in automation of workflow to increase precision and reduce the sample-to-sample variability.

TBRC’s clinical oncology NGS market report covers:

Major Market Players: Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina, F. Hoffmann-La Roche, Perkin Elmer, Agilent Technologies, Pacific Bioscience, and Caris Life Sciences.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Clinical Oncology Next Generation Sequencing Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides clinical oncology next generation sequencing market overviews, analyses and forecasts market size, share, clinical oncology next generation sequencing market players, clinical oncology next generation sequencing market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s clinical oncology next generation sequencing market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Immuno-Oncology Drugs Global Market Report 2021

Oncology Molecular Diagnostics Global Market Report 2021

Oncology Drugs Global Market Report 2021

Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: https://blog.tbrc.info/
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model